Other OTC - Delayed Quote USD

Innovent Biologics, Inc. (IVBXF)

4.8900 0.0000 (0.00%)
At close: April 24 at 10:37 AM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,734,996.0000
-1,918,804.0000
-2,024,843.0000
-307,688.0000
Investing Cash Flow
-1,089,559.0000
-1,435,185.0000
-2,698,148.0000
-5,184,588.0000
Financing Cash Flow
2,913,043.0000
2,892,082.0000
5,003,361.0000
4,912,121.0000
End Cash Position
1,440,531.0000
1,016,165.0000
1,359,408.0000
1,276,178.0000
Capital Expenditure
-1,530,105.0000
-1,381,730.0000
-1,847,516.0000
-771,778.0000
Issuance of Capital Stock
2,142,126.0000
2,131,059.0000
3,950,520.0000
4,662,363.0000
Issuance of Debt
1,527,454.0000
1,080,172.0000
1,463,083.0000
372,178.0000
Repayment of Debt
-854,874.0000
-365,000.0000
-255,000.0000
-17,000.0000
Free Cash Flow
-3,265,101.0000
-3,300,534.0000
-3,872,359.0000
-1,079,466.0000
12/31/2020 - 9/4/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers